Raymond James Trust N.A. Purchases New Stake in Waters Co. (NYSE:WAT)

Raymond James Trust N.A. acquired a new position in shares of Waters Co. (NYSE:WATFree Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,379 shares of the medical instruments supplier’s stock, valued at approximately $454,000.

A number of other large investors also recently added to or reduced their stakes in WAT. American Century Companies Inc. lifted its holdings in Waters by 10.2% in the first quarter. American Century Companies Inc. now owns 6,977 shares of the medical instruments supplier’s stock valued at $2,165,000 after buying an additional 645 shares during the period. Group One Trading L.P. acquired a new stake in shares of Waters during the first quarter worth $135,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Waters by 6.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,167 shares of the medical instruments supplier’s stock valued at $2,535,000 after purchasing an additional 506 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Waters by 1.6% in the first quarter. Dimensional Fund Advisors LP now owns 294,027 shares of the medical instruments supplier’s stock valued at $91,287,000 after buying an additional 4,656 shares during the period. Finally, Prudential PLC boosted its stake in Waters by 39.4% during the 1st quarter. Prudential PLC now owns 4,626 shares of the medical instruments supplier’s stock worth $1,436,000 after acquiring an additional 1,308 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

WAT has been the subject of several research analyst reports. Citigroup boosted their price objective on Waters from $265.00 to $300.00 and gave the company a “neutral” rating in a research report on Monday, December 11th. Stifel Nicolaus increased their price objective on shares of Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a research report on Wednesday, February 7th. TheStreet raised shares of Waters from a “c+” rating to a “b-” rating in a research report on Wednesday, December 13th. Wolfe Research started coverage on Waters in a research report on Wednesday, December 13th. They set a “peer perform” rating for the company. Finally, Barclays raised their price target on shares of Waters from $275.00 to $300.00 and gave the stock an “underweight” rating in a research note on Monday, February 12th. One equities research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $293.50.

View Our Latest Analysis on WAT

Waters Trading Down 1.5 %

NYSE WAT opened at $347.31 on Monday. Waters Co. has a 12 month low of $231.90 and a 12 month high of $363.80. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00. The stock has a 50 day moving average of $330.68 and a 200-day moving average of $297.50. The company has a market cap of $20.56 billion, a PE ratio of 32.01, a PEG ratio of 6.91 and a beta of 0.93.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.06. The firm had revenue of $819.50 million during the quarter, compared to analysts’ expectations of $815.50 million. Waters had a net margin of 21.72% and a return on equity of 81.30%. The company’s revenue for the quarter was down 4.5% compared to the same quarter last year. During the same quarter last year, the company posted $3.84 earnings per share. On average, equities research analysts anticipate that Waters Co. will post 11.89 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Linda Baddour sold 500 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total value of $177,770.00. Following the transaction, the director now directly owns 2,250 shares of the company’s stock, valued at $799,965. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.98% of the stock is currently owned by corporate insiders.

About Waters

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.